Four faces of cellular senescence
Open accessThe DOI matches its Crossref record; 133 of the 137 references it cites were found in a registry or an index; 10 of the 26 sources its claims cite were checked for support.
Abstract
Cellular senescence is an important mechanism for preventing the proliferation of potential cancer cells. Recently, however, it has become apparent that this process entails more than a simple cessation of cell growth. In addition to suppressing tumorigenesis, cellular senescence might also promote tissue repair and fuel inflammation associated with aging and cancer progression. Thus, cellular senescence might participate in four complex biological processes (tumor suppression, tumor promotion, aging, and tissue repair), some of which have apparently opposing effects. The challenge now is to understand the senescence response well enough to harness its benefits while suppressing its drawbacks.
Overview
CoChat Summary
## TL;DR
Cellular senescence is presented as an essentially irreversible growth arrest that suppresses tumor formation, but the paper argues it also has broader roles in tumor promotion, aging, and tissue repair. The authors frame these effects as arising from the senescence-associated secretory phenotype (SASP) and from the context in which senescent cells accumulate.
## Key findings
- Senescence is described as a crucial anticancer mechanism: in human and mouse premalignant lesions, senescent cells are abundant, but they are “markedly diminished” in the malignant tumors that develop from those lesions.
- Senescent cells can promote tumor progression in mouse xenografts: co-injection of senescent fibroblasts with premalignant epithelial cells enabled malignant cancer formation, and co-injection with fully malignant cells “markedly accelerates” tumor formation.
- Senescent cells may contribute to aging and degeneration: transgenic mice with chronically elevated p53 activity showed “shortened life span and premature aging,” including loss of fertility, osteoporosis, sarcopenia, dermal thinning, loss of subcutaneous fat, reduced hair growth, and retarded wound healing.
- In tissue repair, senescence appears beneficial: after acute liver injury, stellate cells undergo senescence, ECM production declines, MMP secretion increases, and mice impaired for senescence because of p53 or p16INK4a/p19ARF deficiencies developed “severe fibrosis” after injury.
## Methods
- This is a narrative review synthesizing prior studies across human tissues, mouse models, cell culture, and mouse xenografts.
- The paper compares senescent versus nonsenescent cells and summarizes experimental perturbations of p53, p16INK4a/pRB, Pten, Klotho, BubR1, p63, and CCN1 in relation to senescence phenotypes.
- Main analysis is interpretive and mechanistic: the authors connect published findings to a model in which senescence has temporally ordered phases, including early growth arrest, SASP induction, and later immune clearance or tissue-level effects.
## Limitations
- The paper itself states that evidence for senescence driving aging is “circumstantial,” and that cause-and-effect cannot yet be tested cleanly because organisms lacking senescence generally die prematurely of cancer.
- It also notes that there are “no definitive answers” for how senescence might promote late-life cancer.
- Evident from the text: many claims rely on mouse models, cell culture, and xenografts rather than direct demonstration in naturally occurring human disease.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
8 Valid · 1 Not valid · 8 Not checked · 28 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“thus p53 can be pro-aging or pro-longevity, depending on the physiological context (de Keizer et al., 2010).”
§ Four faces of cellular senescence > Cellular senescence and aging > Altered p53 function and aging.
What the sources say
- Supportedcites de Keizer et al., 2010 source
The paper states directly that p53 can be either pro-aging or pro-longevity depending on physiological context. It also explains that p53 can promote or retard aging depending on how its activity is regulated. (LLM, conf=0.95)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Low-level, chronic, “sterile” inflammation is a hallmark of aging that initiates or promotes most, if not all, major age-related diseases (Franceschi et al., 2007; Chung et al., 2009).”
§ Four faces of cellular senescence > Cellular senescence and aging > How might senescent cells promote age-related pathologies?
What the sources say
- Not checked — no full text of the sourcecites Franceschi et al., 2007 source
- Partly supportedcites Chung et al., 2009 sourceExperimental — accuracy not yet measured
The Introduction describes chronic, low-grade inflammation as a possible link between aging and the pathogenesis of many age-related diseases; the Conclusion calls it a primary factor underlying aging and numerous age-related diseases. The copy does not characterize the inflammation as “sterile,” and its references to many or numerous diseases do not substantiate “most, if not all.” Page numbers were not available in the indexed passages. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“which comprise a negative feedback loop to dampen NF-κB activity (Taganov et al., 2006; Freund et al., 2010).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion (page not specified in our copy) proposes that NF-κB induces miR-146 genes, which could reduce IRAK1 and TRAF6 levels and thereby dampen pathway activity. The claim presents that proposed negative-feedback effect as established; the paper says further studies are needed to determine miR-146’s exact role. (LLM, conf=0.85)
- Supportedcites Freund et al., 2010 source
The “Chromatin organization” section states that miR-146a/b provide negative feedback that inhibits NF-κB activity. The “microRNAs” section likewise describes them as part of an NF-κB feedback loop. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Whatever the case, the examples above, and a growing list of similar studies (Collado and Serrano, 2010), argue that cellular senescence restrains cancer by imposing a cell-autonomous block to the proliferation of oncogenically damaged/stressed cells (Fig. 2).”
§ Four faces of cellular senescence > Cellular senescence and tumor suppression
What the sources say
- Supportedcites Collado and Serrano, 2010 source
The Introduction (page not provided) describes oncogenically stressed cells stopping division through a cell-cycle arrest and identifies oncogene-induced senescence as a tumour-suppressor mechanism. The Preface adds that senescence stably blocks proliferation and that progression to malignancy requires evading it. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The induction of these miRNAs may prevent the SASP from generating persistent acute (robust) inflammation, which, unlike low-level chronic inflammation, is designed to be self-limiting (Taganov et al., 2006).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion proposes that induced miR-146 could dampen inflammatory signaling through a negative-feedback loop. It does not address the SASP or establish that these miRNAs prevent it from generating persistent acute inflammation; nor does it make the stated comparison with low-level chronic inflammation. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
30 more claims · 2 with their cited sources checked
Create a free account to see all 45 claims and every source verdict.
- It may state two separate claims as one. 4
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased numbers of senescent cells with age are an important contributor to the age-associated increase in inflammation because senescent cells secrete a large number of pro-inflammatory proteins (senescence-associated secretory phenotype, or SASP) (Rodier and Campisi, 2011).”
From The Aging Epigenome (2016) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescence can be triggered by multiple mechanisms, including those resulting in ROS production and oxidative stress (Kuilman et al., 2010; Rodier and Campisi, 2011).”
From mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis (2012) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cells undergoing damage-induced senescence are often cleared by the immune system, as several SASP factors are cytokines and chemokines that can modulate the local immune environment.2,3,5,70,71”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which exhibit various senescence-related phenotypes, like increased size of nucleoli, enlarged and overloaded lysosome, and secretion of senescence-associated secretory phenotype (SASP) factors.5,6,7”
From Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators (2024) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent findings have uncovered an additional beneficial effect of the senescence response and accompanying SASP: the ability to promote optimal repair of damaged tissue (59, 91, 145–147).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [147]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · cited 2×
“Moreover, to form a lethal tumor, cancer cells must acquire a greatly expanded growth potential and ability to proliferate while expressing activated oncogenes (Hanahan and Weinberg, 2000), traits that are suppressed by the senescence program.”
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“First, senescent cells increase with age in a variety of mammalian tissues (Dimri et al., 1995; Paradis et al., 2001; Melk et al., 2003; Erusalimsky and Kurz, 2005; Jeyapalan et al., 2007; Wang et al., 2009).”
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 2×
“…al., 1991; Shay et al., 1991; Bond et al., 1994; Lin et al., 1998; Schmitt et al., 2002; Beauséjour et al., 2003; Collins and Sedivy, 2003; Oren, 2003; Herbig et al., 2004; Jacobs and de Lange, 2004; Ohtani et al., 2004; Chen et al., 2005; Campisi and d’Adda di Fagagna, 2007; Rodier et al., 2007).”
Self-citationTaganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Cited by
Items 1,901–2,000 of 2,013
Exploring the epigenetic link in circadian disruption induced breast cancer
Kochan, D. Z. (2015) · Open ULeth Scholarship (OPUS) (University of Lethbridge)
Lipid metabolic reprogramming regulates macrophage senescence in the tumor microenvironment
Liu, Y., Li, C., Wang, J., Gao, M., & Jiang, S. (2026) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2026.04.002
Death and Immortality: Biological and East Asian Religious Reflections on Transhumanism
김흡영, & 허균 (2017) · Madang Journal of Contextual Theology · doi:10.26590/madang..28.201712.3
Regenerative Medicine to Improve Skeletal Muscle Healing After Injury, Disease, and Aging
Groesbeck, A., Luhmann, M., Singer, J., Knezic, N., Lind, D. R. G., Lopez, L., Robinson, S., & Huard, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-84693-9_24
Howard, G. C. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780190687724.003.0007
O’Connor, J., Herrera, G., Jávega, B., & Martínez‐Romero, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00058-0
Zhou, R., Lin, X., Lin, J., Liao, Z., Ni, H., Lin, X., He, Q., & Ning, W. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103110 · Cited by 3
Howard, G. C. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780190687724.003.0003
Furuya, K., Umeno, Y., Ikura, M., Ikura, Y., Nishikawa, S., & Ikura, T. (2026) · Genes to Cells · doi:10.1111/gtc.70127
“As cellular senescence can exert both beneficial and detrimental effects depending on cellular state, distinguishing pathological senescent cells from beneficial senescent states and tracking their transitions remain important challenges (Rodier and Campisi 2011).”
Metabolomic Biomarkers of Cellular Senescence in Neurodegenerative Disease
Slocum, D. L., Duka, D., Antonelli, L., & Logan, R. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1018049
Caractérisation de la sénescence des cardiomyocytes et identification de marqueurs associés
Maggiorani, D. (2017) · theses.fr (ABES) · doi:10.70675/a58747bczd60bz4482za3b2z7ae33d26ffa4 · Cited by 1
“La cellule sénescente exprime par exemple très fortement p53 et p16INK4a qui sont des gènes suppresseurs de tumeurs (Rodier and Campisi, 2011).”
BackgroundUsando Biologia de Sistemas para entender a Imunossenescência
Passos, F. M. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.95.2018.tde-20230725-114626
Bonnefous, H. (2025) · theses.fr (ABES) · doi:10.70675/67742b4az1242z4d30z964ezd8bf9300d4ac · Cited by 1
Cancer as a script and possible implications on workings of genomePreprint
Khan, M. (2014) · doi:10.7287/peerj.preprints.126v3
Editorial: Special issue cellular aging
Zwerschke, W. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111065
Kim, Y. Y., Um, J., & Yun, J. (2018) · Journal of Visualized Experiments · doi:10.3791/57890 · Cited by 2
Homeostatic conflict as a driver for brain aging
Wulkop-Gil, C. A., & Petrascheck, M. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1881856
Subtelomere-Telomere Aging Theory
Libertini, G., Corbi, G., Conti, V., Shubernetskaya, O. S., & Ferrara, N. (2021) · Advances in studies of aging and health · doi:10.1007/978-3-030-73774-0_5
Li, W., Kawaguchi, K., Tanaka, S., He, C., Maeshima, Y., Suzuki, E., & Toi, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.08.536098
Guo, Y. P., Chomiak, A. A., Hong, Y., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3937606
Cellular mechanisms of myofibroblast differentiation and dysfunctions in wound healing
Midgley, A. C. (2014) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 1
Howard, G. C. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780190687724.003.0010 · Cited by 1
The Self-Organisation of Biological Soft matter Systems at Different Length-scales
Blumlein, A. (2016) · Maynooth University ePrints and eTheses Archive (Maynooth University)
The love and hate relationship between cellular senescence and stemness
Papaspyropoulos, A., Theocharous, G., Ntintas, O. A., Evangelou, K., & Gorgoulis, V. G. (2026) · Aging · doi:10.18632/aging.206387 · Cited by 2
“Senescent cells acquire a unique secretome termed Senescence-Associated Secretory Phenotype (SASP), accompanied by characteristic morphological and functional changes due to alterations in cellular shape and genetic/epigenetic regulation, as well as extensive metabolic rewiring [1, 2, 4].”
InfluentialDing, C., Ye, Z., Zeng, P., & Chen, W. (2026) · PLoS ONE · doi:10.1371/journal.pone.0353694
“GSE24206 was used as a validation dataset, including 6 normal and 17 IPF tissue samples (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE24206) [24].”
Senescence Under the Lens: X-ray vs. Proton Irradiation at Conventional and Ultra-High Dose Rate
Meester, M.-E. D., Paulus, H., Michiels, C., Heuskin, A., & Debacq‐Chainiaux, F. (2025) · Radiation Research · doi:10.1667/rade-25-00071.1 · Cited by 1
The vicious cycle of SASP and inflammaging promotes aging and age-related diseases
Liu, Q., Zheng, Y., & Sun, C. (2026) · Communications Biology · doi:10.1038/s42003-026-10826-4 · Cited by 1
“Interestingly, although p53 and p16 are canonical mediators of growth arrest, SASP can still be generated even in the absence or inhibition of p53 and p16 INK4a , indicating the existence of alternative regulatory mechanisms 3,86 .”
Libertini, G., Corbi, G., Shubernetskaya, O. S., Komici, K., & Ferrara, N. (2024) · Advances in studies of aging and health · doi:10.1007/978-3-031-84877-3_8
Cellular Senescence as a Novel Mechanism of Chronic Inflammation and Cancer Progression
Ohtani, N. (2016) · Springer eBooks · doi:10.1007/978-4-431-56068-5_15
Howard, G. C. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780190687724.002.0006
Influence of Pyruvate Kinase Isoform Expression on Primary Cell Proliferation and Metabolism
Muralidhar, V. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 2
Senescence And The Senescence Associated Secretory Phenotype In Salivary Hypofunction
Jean-Baptiste, Q. (2024) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/2f5r-h13w
A Contraindication for Transplantation? Consequences of Frailty on Immunity and Immunosuppression
Nian, Y., Maenosono, R., Iske, J., Elkhal, A., & Tullius, S. G. (2019) · Current Transplantation Reports · doi:10.1007/s40472-019-0228-y
Research Progress on Telomerase Activity Assays: From Traditional Methods to Novel Technologies
He, S., Zhang, M., Cheng, J., Xu, Y., & Zhong, X. (2026) · ACS Omega · doi:10.1021/acsomega.6c04780
Thavaneswaran, S., Sebastian, L. T., Kansara, M., Ballinger, M. L., Espinoza, D., Lin, F., Lee, C. K., Sjoquist, K. M., Grady, J. P., Cowley, M. J., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-254137/v1
αG-Rutin Mitigates Telomere Attrition and Prevents Cellular Senescence
Terada, T., Sahayasheela, V. J., Noizumi, R., Nakanishi, A., Tandia, M., & Sugiyama, H. (2025) · ACS Nutrition Science · doi:10.1021/acsnutrsci.5c00012
Rôle de l’immunosurveillance des cellules sénescentes dans le cancer et le vieillissement
Iltis, C. (2020) · theses.fr (ABES) · doi:10.70675/9a339b58z5fecz427dz8de4z8ce0bd748478 · Cited by 1
Tumor Microenvironment: Coconspirator in Tumorigenesis
Wang, Z. (2022) · Springer eBooks · doi:10.1007/978-3-030-93084-4_3
Natural variations in yeast aging reveal genetic and environmental factors
Barré, B. P. (2018) · theses.fr (ABES) · doi:10.70675/ea0d9b85zd8b9z4fedzae80z738885fb5ca4
Non-autonomous Tumor Progression by Oncogenic Inflammation
Ohsawa, S., & Igaki, T. (2016) · Springer eBooks · doi:10.1007/978-4-431-56068-5_17
Dow, C. T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15500-0.00007-4
Wu, W. (2024) · Research Publications (Maastricht University) · doi:10.26481/dis.20240628ww
Maulucci, G., & Pani, G. (2012)
Dey, A. (2016) · UCL Discovery (University College London)
Nuclear Protein Pirin Negates the Cellular Senescence Barrier Against Cancer Development
Licciulli, S., & Alcalay, M. (2013) · Springer eBooks · doi:10.1007/978-94-007-7726-2_14
P16 promotes aging-induced lipid droplet accumulation via up-regulation of PCSK9 in hepatocytesPreprint
Hao, N., Peng, C., Shi, Y., Liu, C., Qiu, Y., Yong, H., Gu, X., & Wang, F. (2023) · Research Square · doi:10.21203/rs.3.rs-2838622/v1
van Splunter, M. (2018) · doi:10.18174/453828 · Cited by 1
Ashes to Ashes and Dust to Dust
Howard, G. C. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780190687724.003.0006
Cellular Mechanisms in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Rojas, M. M., Albacar, N., & Cuerpo, S. (2021) · Barcelona Respiratory Network · doi:10.23866/brnrev:2020-0010
Teissier, T. (2019) · theses.fr (ABES) · doi:10.70675/f49bc069z5ee6z4c49zb46fz0a1413dbba95
Ghousein, A. (2018) · theses.fr (ABES) · doi:10.70675/ec7734c8zd6cdz40d5z9291ze7613c3b0d23
Nucleic acid fluorescent probes for telomerase assay
Wang, J., Ouyang, H., Lou, X., Xia, F., Dai, J. Y., & Li, K. (2026) · NPG Asia Materials · doi:10.1038/s41427-026-00663-6
“…is frequently observed in a wide range of cancers, including breast cancer, ovarian cancer, lung cancer, prostate cancer, colorectal cancer, acute leukemia , gastric cancer 3 – 9 and bladder cancer 10 , as well as some non-cancerous conditions like liver cirrhosis and certain genetic disorders 11 .”
In search of a wide-angle perspective
Rosenthal, N. A., & Stewart, C. L. (2012) · Differentiation · doi:10.1016/j.diff.2012.02.003
Signaling Networks Controlling Cellular Senescence
Desai, L. P., Sanders, Y. Y., & Thannickal, V. J. (2014) · Wiley eBooks · doi:10.1002/9781118396292.ch6
Ngo, K. (2015) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Caravello, A., & Blidy, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1861044
“Senescent cells (53, 54, 56, 65) secrete a characteristic cytokine pro fi le (SASP) dominated by IL-6, IL-1 b , TNF-a , and TGF-b , with additional contributions from PGE2, CXCL12, and amphiregulin (31 – 34).”
Bell, M. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780190687724.002.0008
ADP Inhibits Macrophage Senescence via the AMPK / KLF10 Pathway in Systemic Lupus Erythematosus
Yang, S., Li, Z., Zhao, Y., Shao, M., Zhang, X., Wang, S., Zheng, L., Liu, J., Yang, Q., Wan, J., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202603249r
“SASP modulates resident and infiltrating cell populations, thereby reinforcing cell cycle arrest and exacerbating inflammatory responses [11, 12].”
Generation and Gene Expression of CD28−CD8 T Cells in Human
Kim, J., & Weng, N. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_17-1
Combined cancer therapy using gold nanoparticles
Yang, C. J. (2021) · doi:10.32920/ryerson.14661873.v1
Why pregnancy is not a disease: a critique from the perspective of biological trade-offs
Wang, X. (2025) · Journal of Medical Ethics · doi:10.1136/jme-2025-111409
“16 However, this very mechanism of clearing potentially cancerous cells, in its cumulative effect, also constitutes the process of organismal ageing.”
Arora, C. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/269738
“Since there is a linear relationship between IL6 and Akt [47], so, an extra equation for Akt is not required and the concentration of Akt is taken to be directly proportional to IL6.”
BackgroundSchneider, S. E., Scott, A. K., Gallagher, K. M., Miller, E. Y., Ghosh, S., & Neu, C. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.16.643588
Impact of aging on cardiac mesenchymal stromal cells
Martini, H. (2019) · theses.fr (ABES) · doi:10.70675/bb7ddcb3z0b6az4c39za6eczc94e0563f0a3
senescenceincreases CCN1 expression leading to muscle
Du, J., Klein, J. D., Hassounah, F., Zhang, J., Zhang, C., & Wang, X. H. (2016)
Recent Advances in the Study of Biomarkers of Aging
肖, 夤. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153869
Sharoni, E. Y. (2021) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Is Senescence Important in Hepatic Diseases?
Pacheco-Rivera, R., Arellanes‐Robledo, J., & Serrano‐Luna, J. (2017) · InTech eBooks · doi:10.5772/intechopen.68587
“In addition to specific parenchymal or nonparenchymal liver structures, studies have highlighted the appearance of CS in two paradoxical settings, as a tumor suppressor and as a tumor promoter, and in two physiological processes, aging and tissue repair [57, 58].”
BackgroundLindgren, T. (2013) · DiVA (Digitala Vetenskapliga Arkivet)
IRF1 Inhibits Therapy-Induced Senescence of Glioblastoma Cells Through OAS2
Ma, G., Huang, W., Yan, H., Shen, B., Zhu, S., & Xu, X. (2026) · Cells · doi:10.3390/cells15131149
“Attenuated cell proliferation is a hallmark of cellular senescence [11,39].”
Djabali, K. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112255
Howard, G. C. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780190687724.003.0001
Kojima, H., Kunimoto, H., Inoue, T., & Nakajima, K. (2013) · Springer eBooks · doi:10.1007/978-94-007-7726-2_6
Han, H., Zhao, F., Wang, J., Zhai, J., & Zhu, G. (2026) · Life · doi:10.3390/life16060984 · Cited by 1
“In clinical radiotherapy, fractionated regimens commonly deliver single doses of 1.8–2.5 Gy, which can induce sublethal damage in adjacent normal tissues, provoking sustained oxidative stress and low-grade chronic inflammation, key drivers of persistent cellular senescence [38].”
InfluentialSalmenperä, P. (2012) · Työväentutkimus Vuosikirja
DNA Damage and Checkpoint Responses in Adult Stem Cells
Romanov, V. S., Shukla, A., & Ju, Z. (2014) · Else Kröner-Fresenius Symposia · doi:10.1159/000366568
Cellular Senescence and Premature Aging in Lung Diseases
Aoshiba, K., Tsuji, T., Yamaguchi, K., Itoh, M., & Nakamura, H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397803-5.00017-4
Waaijer, M. E. C., Tuttle, C. S. L., Westendorp, R. G. J., & Maier, A. B. (2018) · VU Research Portal
Gómez-García, J. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Osaki, J. H. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2015.tde-22092015-075415 · Cited by 1
Liu, X., Guo, Y., Popa‐Wagner, A., Lämmermann, I., Grillari, J., & Hermann, D. M. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103206 · Cited by 1
Cellular Senescence in Pterygium
Kim, J. H., Lee, S. J., Lee, K. W., & Kim, J. (2020) · Journal of the Korean Ophthalmological Society · doi:10.3341/jkos.2020.61.8.861 · Cited by 1
Howard, G. C. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780190687724.003.0015
Wassmer, G., Hmitti, Z., Voisin, L., & Perfettini, J. (2018) · médecine/sciences · doi:10.1051/medsci/20183401011
Li, L. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0167674
“Senescence is characterized by a much larger flattened cytoplasm containing many vacuoles and expression of acidic senescence-associated βgalactosidase (Campisi, 2013; Provinciali et al., 2013; Rodier and Campisi, 2011).”
The genetic architecture of plasma cell disorders
Boyle, E. M. (2020) · theses.fr (ABES) · doi:10.70675/404c872dz0ef2z4f8eza81fz592360ed443b · Cited by 1
Role of Altered Extracellular Signalling in Cellular Senescence
Takasugi, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11427-8
Metadata
- Authors
- Rodier, F., & Campisi, J.
- Affiliations
- The Research Centre of the University of Montreal Hospital Centre/Institut du Cancer de Montréal, Montreal, Quebec, H2L 4M1 Canada 1
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- ORCID
- Campisi, Judith
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2011-02-14
- Volume
- 192
- Issue
- 4
- Pages
- 547-556
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3044123
- OpenAlex
- W2077450385
- Cited by
- 2,070
- References
- 137
- Citations by year
- 2026: 65 · 2025: 94 · 2024: 101 · 2023: 131 · 2022: 113 · 2021: 164 · 2020: 175 · 2019: 154 · 2018: 164 · 2017: 160 · 2016: 162 · 2015: 162 · 2014: 147 · 2013: 126 · 2012: 108
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- U.S. Department of Energy
- Cancer Research Society
- Institut Du Cancer de Montréal
- National Institutes of Health
- National Cancer Institute
- Institute of Cancer Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, tumor suppression, tumor promotion, aging, tissue repair, inflammation, tumor progression, senescence-associated secretory phenotype, senescence-associated inflammation
- MeSH terms
- Aging, Animals, Humans, Models, Biological, Neoplasms, Wound Healing, Signal Transduction, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.